Search - tctmd.com

Displaying 61 - 78 of 78

Sort: Relevancy | Date

News Industry News

Medtronic Announces FDA Approval of New Portfolio of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators

May 06, 2013

News Industry News

CardioGuide System Enables Real-Time Navigation of Left Ventricular Leads During Medtronic CRT Implants

April 09, 2013

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

News Industry News

Vascular Nanotransfer Technologies (“VNT”) reports in vivo results for its paclitaxel nano-carrier based drug coated balloon (DCB) technology

October 19, 2012

News Industry News

Medtronic Receives FDA Approval, CE Mark for Arctic Front Advance™ Cardiac Cryoballoon to Treat Atrial Fibrillation

August 24, 2012

News Industry News

Arterial Remodeling Technologies (ART) reports first human use of its next-generation bioresorbable stent

July 16, 2012

News Industry News

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

July 03, 2012

News Industry News

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

July 02, 2012

News Industry News

Hansen Medical Receives FDA 510(k) Clearance for its Magellan™ Robotic System for Peripheral Vascular Interventions

June 04, 2012

News Industry News

ART receives receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent

May 15, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Industry News

Arterial Remodeling Technologies (“ART”) reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

November 02, 2011

News Industry News

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

July 18, 2011

News Industry News

Study Confirms that OrbusNeich's GenousTM Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity

July 11, 2011

News Industry News

Advanced Cardiac Therapeutics Announces CE Mark Clearance For Innovative Catheter System for the Treatment of Atrial Arrhythmias

June 10, 2011

News Industry News

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

May 18, 2011

News Industry News

Data From Multiple Clinical Trials of OrbusNeich's GenousTM Stent Set for Presentation at EuroPCR 2011

May 12, 2011

News Industry News

OrbusNeich Granted Expanded U.S. Patent of GenousTM Endothelial Progenitor Cell Capture Technology

January 03, 2011

Advertisement

Medtronic Announces FDA Approval of New Portfolio of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators

CardioGuide System Enables Real-Time Navigation of Left Ventricular Leads During Medtronic CRT Implants

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

Vascular Nanotransfer Technologies (“VNT”) reports in vivo results for its paclitaxel nano-carrier based drug coated balloon (DCB) technology

Medtronic Receives FDA Approval, CE Mark for Arctic Front Advance™ Cardiac Cryoballoon to Treat Atrial Fibrillation

Arterial Remodeling Technologies (ART) reports first human use of its next-generation bioresorbable stent

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

Hansen Medical Receives FDA 510(k) Clearance for its Magellan™ Robotic System for Peripheral Vascular Interventions

ART receives receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

Arterial Remodeling Technologies (“ART”) reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

Study Confirms that OrbusNeich's GenousTM Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity

Advanced Cardiac Therapeutics Announces CE Mark Clearance For Innovative Catheter System for the Treatment of Atrial Arrhythmias

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

Data From Multiple Clinical Trials of OrbusNeich's GenousTM Stent Set for Presentation at EuroPCR 2011

OrbusNeich Granted Expanded U.S. Patent of GenousTM Endothelial Progenitor Cell Capture Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content